Vitro Biopharma, Inc. filed its 10-K on Jan 30, 2023 for the period ending Oct 31, 2022. In this report its auditor, Malone & Bailey, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
1st Jan change | Capi. | |
---|---|---|
+2.97% | 94.74B | |
-3.68% | 37.28B | |
-12.37% | 32.68B | |
+74.21% | 27.72B | |
-14.15% | 16.19B | |
-2.48% | 13.88B | |
-12.21% | 11.58B | |
+188.83% | 10.92B | |
-53.94% | 9.54B |